• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcellx, Inc. - Common Stock (NQ:ACLX)

115.07 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, Apr 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 115.07
Bid (Size) 115.05 (10,000)
Ask (Size) 115.14 (9,400)
Prev. Close 115.07
Today's Range 115.07 - 115.07
52wk Range 47.86 - 115.13
Shares Outstanding 48,358,981
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Gilead Extends Tender Offer for Arcellx as Biotech M&A Sentiment Faces a Reality Check
April 06, 2026
Gilead Sciences (NASDAQ: GILD) announced a strategic extension of its tender offer to acquire cell therapy innovator Arcellx (NASDAQ: ACLX) on April 1, 2026. Originally scheduled to expire on April 2,... 
Via MarketMinute
News headline image
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution
March 31, 2026
In a move that signals a decisive shift in the treatment of chronic autoimmune conditions, Gilead Sciences (NASDAQ:GILD) announced on March 23, 2026, its definitive agreement to acquire Ouro Medicines... 
Via MarketMinute

Performance

YTD
+81.7%
+81.7%
1 Month
+0.3%
+0.3%
3 Month
+68.9%
+68.9%
6 Month
+33.8%
+33.8%
1 Year
+77.8%
+77.8%

More News

Read More
News headline image
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? ↗
March 22, 2026
Via The Motley Fool
News headline image
The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips
March 19, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Workforce
News headline image
Halper Sadeh LLC is Investigating Whether KW, ACLX are Obtaining Fair Deals for their Shareholders
March 19, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether SEM, UNF, ACLX, FONR are Obtaining Fair Deals for their Shareholders
March 17, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗
March 16, 2026
Via The Motley Fool
News headline image
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally ↗
March 16, 2026
Via The Motley Fool
News headline image
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal ↗
March 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX
March 13, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Halper Sadeh LLC is Investigating Whether BCO, THR, ACLX are Obtaining Fair Deals for their Shareholders
March 05, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether ACLX, VRE, EHAB are Obtaining Fair Deals for their Shareholders
March 04, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Arcellx President Sells $10 Million Worth of Shares After Acquisition Announcement ↗
March 02, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Arcellx President Sells $10M Worth of Shares After Acquisition Announcement ↗
March 02, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Halper Sadeh LLC is Investigating Whether ACLX, EHAB, VRE are Obtaining Fair Deals for their Shareholders
February 24, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX
February 23, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
Let's take a look at the stocks that are in motion in today's session. ↗
February 23, 2026
Via Chartmill
Here are the top movers in Monday's session. ↗
February 23, 2026
Via Chartmill
These stocks are gapping in today's session ↗
February 23, 2026
Via Chartmill
These stocks are moving in today's pre-market session ↗
February 23, 2026
Via Chartmill
News headline image
ACLX Stock Alert: Halper Sadeh LLC is Investigating Whether Arcellx, Inc. is Obtaining a Fair Price for its Shareholders
February 23, 2026
From Halper Sadeh LLC
Via Business Wire
News headline image
Why Did ACLX Stock Surge 80% In Pre-Market Today? ↗
February 23, 2026
Via Stocktwits
News headline image
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
February 23, 2026
From Arcellx, Inc.
Via Business Wire
News headline image
$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges ↗
February 22, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
February 17, 2026
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Arcellx, Inc. - Common Stock publicly traded?
Yes, Arcellx, Inc. - Common Stock is publicly traded.
What exchange does Arcellx, Inc. - Common Stock trade on?
Arcellx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Arcellx, Inc. - Common Stock?
The ticker symbol for Arcellx, Inc. - Common Stock is ACLX on the Nasdaq Stock Market
What is the current price of Arcellx, Inc. - Common Stock?
The current price of Arcellx, Inc. - Common Stock is 115.07
When was Arcellx, Inc. - Common Stock last traded?
The last trade of Arcellx, Inc. - Common Stock was at 04/27/26 04:15 PM ET
What is the market capitalization of Arcellx, Inc. - Common Stock?
The market capitalization of Arcellx, Inc. - Common Stock is 5.56B
How many shares of Arcellx, Inc. - Common Stock are outstanding?
Arcellx, Inc. - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap